PD38: Urodynamics/Lower Urinary Tract Dysfunction/Female Pelvic Medicine: Non-neurogenic Voiding Dysfunction II

Podium Session Moderator(s)

• 

  Gary Lemack, MD

  University of Texas Southwestern Medical Center
• 

  Eric Rovner, MD

  MD
  Medical University of South Carolina
• 

  Priya Padmanabhan, MD, FACS, MPH

  Professor
  OU William Beaumont School of Medicine

Presentations:

• 7:00 AM – 7:10 AM

  PD38-01: Feasibility, safety and efficacy results of the SUFU Foundation open label clinical trial of ultrasound confirmed transvaginal botulinum toxin A (BTA) for refractory overactive bladder (OAB)
  

  Podium Presenter: Sean Berquist, MD
• 7:10 AM – 7:20 AM

  PD38-02: 10-year follow-up observation of idiopathic detrusor underactivity in the elderly living in community: Treatment and urodynamic changes
  

  Podium Presenter: Seong Jin Jin Jeong, MD – Seoul National University Bundang Hospital
• 7:20 AM – 7:30 AM

  PD38-03: Role of post-voided residual ratio in patients with detrusor underactivity: a pressure-flow study analysis
  

  Podium Presenter: Antonio Nacchia
• 7:30 AM – 7:40 AM

  PD38-04: A community-based education program for overactive bladder in a predominantly minority older female population: a pilot study
  

  Podium Presenter: Susana Martinez Diaz
• 7:40 AM – 7:50 AM

  PD38-05: Excessive visceral fat in men is associated with the presence and severity of overactive bladder
  

  Podium Presenter: Tomohiro Matsuo
• 7:50 AM – 8:00 AM

  PD38-06: TURPUDU Trial- A prospective study evaluating the effect of transurethral resection of prostate on urodynamic parameters in patients of benign enlargement of prostate with upper urinary tracts dilatation
  

  Podium Presenter: Shantanu Tyagi, MBBS, MS
• 8:00 AM – 8:10 AM

  PD38-07: High Flow Bladder Outlet Obstruction in Men
  

  Podium Presenter: Aaron Huang, BA
• 8:10 AM – 8:20 AM

  PD38-08: Efficacy of low-intensity shock wave therapy on persistent storage symptoms after transurethral surgery for benign prostatic obstruction: Preliminary results of a randomized controlled trial
  

  Podium Presenter: Mohammed Hegazy
• 8:20 AM – 8:30 AM

  PD38-09: AUA-Symptom Scale Is Not Reliable For Use in Measuring Storage Phase Dysfunction
  

  Podium Presenter: Taylor Sadun, MD
• 8:30 AM – 8:40 AM

  PD38-10: Upright Open MRI with standing Yoga poses indicates that postural effects on the bladder neck and urethra occur relevant to female urinary incontinence.
  

  Podium Presenter: Lynn Stothers, MD
• 8:40 AM – 8:50 AM

  PD38-11: Long-Term Efficacy and Safety of Vibegron for Overactive Bladder in Patients &[ge]65 Years Old: Analysis From the EMPOWUR Extension Trial
  

  Podium Presenter: Jeffrey Marc Frankel, MD
• 8:50 AM – 9:00 AM

  PD38-12: Long-Term Patient-Reported Outcomes of Vibegron for Overactive Bladder: Analyses From the EMPOWUR Extension Trial
  

  Podium Presenter: David R. Staskin, MD